Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab + carboplatin/paclitaxel vs placebo + carboplatin/paclitaxel in non-squamous NSCLC (CTR20130887)
CTR20130887Phase 3Active
- Sponsor
- Roche
- Start
- Mar 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in non-small cell lung cancer (NSCLC), sponsored by Roche. Started Mar 2015; status: active.
02
Drugs
bevacizumab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on CTR20130887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130887.